NEW YORK (Reuters Health) – A single pediatric dose of adjuvanted vaccine against pandemic influenza A/H1N1 (pH1N1) is better than 80% effective at 10 days after administration for…
NEW YORK (Reuters Health) – A new study provides more evidence that influenza vaccine reduces major cardiovascular events in patients hospitalized for acute coronary syndrome (ACS). In the…
NEW YORK (Reuters Health) – Vaccinating pregnant women against influenza is a highly effective way of keeping their infants from being hospitalized with influenza in the first six…
NEW YORK (Reuters Health) – Results of a clinical trial of the new, long-acting neuraminidase inhibitor laninamivir octanoate show that it is not inferior to oseltamivir in treating…
NEW YORK (Reuters Health) – Children 1 to 3 years old with influenza benefit substantially from treatment with oseltamivir when it’s given within 24 hours of symptom onset,…
NEW YORK (Reuters Health) Extended-duration treatment with the neuraminidase inhibitors (NAIs) oseltamivir or zanamivir can help prevent symptomatic influenza in immunocompetent adults, a review and analysis of trial…
NEW YORK (Reuters Health) – The results of a new study indicate that the intradermal vaccination route offers greater protection against influenza than the standard intramuscular route in…
Francis Cordova, MD, Medical Director, Lung Transplantation Program, Temple University School of Medicine, discusses indications for lung transplantation in COPD patients and the use of the BODE index.…
Kathleen Brennan, MD, Director of the Pulmonary Outpatient Clinic at Temple University School of Medicine, discusses the indications for pneumococcal vaccination. References and Resources Deuter, C., et al.…
Dr. Danielle Zerr at Seattle Children’s Hospital discusses the CDC’s latest recommendation for childhood flu shots. References and Resources Key Facts About Seasonal Flu Vaccine Children and the…